134 related articles for article (PubMed ID: 34245196)
1. CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract.
Girard N; Marin C; Hélias-Rodzewicz Z; Villa C; Julié C; de Lajarte-Thirouard AS; de Beauce SM; Lagorce-Pages C; Renaud F; Cazals-Hatem D; Guedj N; Cros J; Raffin-Sanson ML; Selves J; Terris B; Fléjou JF; Garchon HJ; Coindre JM; Emile JF
Genes Chromosomes Cancer; 2021 Nov; 60(11):723-732. PubMed ID: 34245196
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous malignant glomus tumor with an MIR143(CARMN)::NOTCH2 fusion.
Larsen N; Pavlidakey P; Harada S; Prieto-Granada CN
J Cutan Pathol; 2023 Feb; 50(2):101-103. PubMed ID: 36324047
[No Abstract] [Full Text] [Related]
3. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.
Mosquera JM; Sboner A; Zhang L; Chen CL; Sung YS; Chen HW; Agaram NP; Briskin D; Basha BM; Singer S; Rubin MA; Tuschl T; Antonescu CR
Genes Chromosomes Cancer; 2013 Nov; 52(11):1075-87. PubMed ID: 23999936
[TBL] [Abstract][Full Text] [Related]
4. A Molecular Reappraisal of Glomus Tumors and Related Pericytic Neoplasms With Emphasis on NOTCH-gene Fusions.
Agaram NP; Zhang L; Jungbluth AA; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Nov; 44(11):1556-1562. PubMed ID: 32604167
[TBL] [Abstract][Full Text] [Related]
5. Gastric glomus tumor on EUS-FNA-based cytology: clinicopathologic and immunohistochemical features of 4 cases, including 1 case with associated MIR143HG-NOTCH2 fusion gene.
Aryal SC; Husain S; Zhang Z; Yuan L
J Am Soc Cytopathol; 2023; 12(4):296-306. PubMed ID: 37072283
[TBL] [Abstract][Full Text] [Related]
6. Gastroesophageal Glomus Tumors: Clinicopathologic and Molecular Genetic Analysis of 26 Cases With a Proposal for Malignancy Criteria.
Papke DJ; Sholl LM; Doyle LA; Fletcher CDM; Hornick JL
Am J Surg Pathol; 2022 Oct; 46(10):1436-1446. PubMed ID: 35703141
[TBL] [Abstract][Full Text] [Related]
7. Novel ATG7::RAF1 gene fusion in malignant glomus tumor.
Shafi S; Jones D; Iwenofu OH; Satturwar S
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23202. PubMed ID: 37724934
[TBL] [Abstract][Full Text] [Related]
8. BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.
Karamzadeh Dashti N; Bahrami A; Lee SJ; Jenkins SM; Rodriguez FJ; Folpe AL; Boland JM
Am J Surg Pathol; 2017 Nov; 41(11):1532-1541. PubMed ID: 28834810
[TBL] [Abstract][Full Text] [Related]
9. Transducing-Like Enhancer of Split 1: A Potential Immunohistochemical Marker for Glomus Tumor.
Bozdogan N; Dilek GB; Benzer E; Karadeniz M; Bozdogan O
Am J Dermatopathol; 2017 Jul; 39(7):524-527. PubMed ID: 28632567
[TBL] [Abstract][Full Text] [Related]
10. Pathogenetic Dichotomy in Angioleiomyoma.
Panagopoulos I; Andersen K; Brunetti M; Gorunova L; Kostolomov I; Kildal W; Hognestad HR; Lobmaier I; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(6):556-566. PubMed ID: 37889065
[TBL] [Abstract][Full Text] [Related]
11. Translocation (1;5) in a Glomus Tumor.
Nishio J; Nabeshima K; Mori S; Naito M
Anticancer Res; 2015 Nov; 35(11):6167-70. PubMed ID: 26504045
[TBL] [Abstract][Full Text] [Related]
12. CircRNAs as Potential Biomarkers in Gastrointestinal Tract Tumors: Opportunities and Challenges.
Liu C; Liu N; Cao B; Zhou Z; Yang G; Zhou P
Clin Lab; 2018 Jan; 64(1):141-145. PubMed ID: 29479890
[TBL] [Abstract][Full Text] [Related]
13. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.
Sun Y; Gao X; Liu J; Kong QY; Wang XW; Chen XY; Wang Q; Cheng YF; Qu XX; Li H
Arch Pathol Lab Med; 2011 Apr; 135(4):451-8. PubMed ID: 21466361
[TBL] [Abstract][Full Text] [Related]
14. Ossified uncertain malignant potential gastric glomus tumor with tumor thrombus.
Guvendir I; Zemheri IE; Altundal K; Ozdil K; Kahraman R; Tosun I
Indian J Pathol Microbiol; 2021; 64(2):369-372. PubMed ID: 33851637
[TBL] [Abstract][Full Text] [Related]
15. Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract.
Stockman DL; Miettinen M; Suster S; Spagnolo D; Dominguez-Malagon H; Hornick JL; Adsay V; Chou PM; Amanuel B; Vantuinen P; Zambrano EV
Am J Surg Pathol; 2012 Jun; 36(6):857-68. PubMed ID: 22592145
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
Li G; Zhang Z; Chen Z; Liu B; Wu H
Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
[TBL] [Abstract][Full Text] [Related]
17. A rare mutation in a rare tumor--SMARCB1-deficient malignant glomus tumor.
Dabek B; Kram A; Kubrak J; Kurzawski M; Wojcik P; Machnicki MM; Stoklosa T; Rydzanicz M; Ploski R; Debiec-Rychter M
Genes Chromosomes Cancer; 2016 Jan; 55(1):107-9. PubMed ID: 26391213
[No Abstract] [Full Text] [Related]
18. MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.
Liu W; Li M; Chen X; Zhu S; Shi H; Zhang D; Cheng C; Li B
Sci Rep; 2018 Mar; 8(1):5183. PubMed ID: 29581534
[TBL] [Abstract][Full Text] [Related]
19. Oesophageal glomus tumours: rare neoplasms with aggressive clinical behaviour.
Birkness-Gartman JE; Wangsiricharoen S; Lazar AJ; Gross JM
Histopathology; 2023 Jun; 82(7):1048-1055. PubMed ID: 36788021
[TBL] [Abstract][Full Text] [Related]
20. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
